Evaluation of polidocanol for the treatment of anal fistula: an experimental study in rats
Acta Cirúrgica Brasileira · 2026 · 41
DOI: 10.1590/acb416826 ↗Abstract
ABSTRACT Purpose: Anal fistula treatment remains challenging, with no single ideal surgical approach. This study introduces a novel technique using polidocanol, a sclerosing agent successful in varicose vein therapy, evaluating its local effects on surgically induced anal fistulas in rats. Methods: In 30 Wistar rats, two separate anal fistulas were created per animal, allowing each rat to serve simultaneously as control (saline-treated) and intervention subject (polidocanol-treated). Outcomes were evaluated at two and four weeks post-injection. Drug effects on the tract and surrounding tissues were assessed via macroscopic and microscopic examinations. Macroscopic analysis focused on local necrosis and external orifice persistence. Histopathology evaluated tract persistence, epithelial lining, and adjacent fibrosis or necrosis, while histomorphometric quantified luminal epithelial tissue. Results: Histopathology documented polidocanol’s intended primary action: destruction of the epithelial layer of the fistulous lumen, corroborated by histomorphometry. Both the mean epithelial height and the epithelial-to-lumen area ratio were significantly lower in the polidocanol-treated group. Conclusion: Local polidocanol injection effectively destroys the epithelial lining of the tract, representing a viable, minimally invasive therapeutic alternative for obliterating anal fistulas.
EUVIMED